The Economic Viability of Antiretroviral Adherence Interventions

American Journal of Medicine

Volumn 115, Issue 8, 2003, Pages 672-673

  Bozzette, Samuel A ^a,b,c   Gifford, Allen L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RAND CORPORATION   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; EDITORIAL; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MONTE CARLO METHOD; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SIMULATION; TREATMENT OUTCOME;

EID: 0344305524     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.09.023     Document Type: Editorial

References (7)

1. Goldie S.J., Paltiel A.D., Weinstein M.C., et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 115:2003;632-641.
2. Mellors J.W., Rinaldo C.R. Jr, Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
3. Paterson D.L., Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 133:2000;21-30.
4. Arnsten J.H., Demas P.A., Farzadegan H., et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users comparison of self-report and electronic monitoring . Clin Infect Dis. 33:2001;1417-1423.
5. Bangsberg D.R., Charlebois E.D., Grant R.M., et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 17:2003;1925-1932.
6. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications (Cochrane Review). In: The Cochrane Library. Oxford, United Kingdom: Update Software; 2003.
7. Freedberg K.A., Losina E., Weinstein M.C., et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 344:2001;824-831.